← Martin B. Leon

Papers by Martin B. Leon

Page 4 · newest first

151. The Current Landscape of Transcatheter Tricuspid Valve InterventionJournal of the Society for Cardiovascular Angiography & Interventions · 2023
152. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND studyEuropean Heart Journal · 2023
153. Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve RegistryEuropean Journal of Heart Failure · 2023
154. Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve interventionCatheterization and Cardiovascular Interventions · 2023
155. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five YearsNew England Journal of Medicine · 2023
156. The Mortality Burden of Untreated Aortic StenosisJournal of the American College of Cardiology · 2023
157. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial FibrillationCirculation · 2023
158. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsThe Annals of Thoracic Surgery · 2023
159. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsEuropean Heart Journal · 2023
160. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsJournal of the American College of Cardiology · 2023
161. Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve ReplacementStructural Heart · 2023
162. Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 2Journal of the Society for Cardiovascular Angiography & Interventions · 2023
163. Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1Journal of the Society for Cardiovascular Angiography & Interventions · 2023
164. Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosisEuroIntervention · 2023
165. Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIEuroIntervention · 2023
166. Transcatheter aortic valve‐in‐valve implantation within stentless landing zones: Procedural insights from a single‐center experienceCatheterization and Cardiovascular Interventions · 2023
167. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationAmerican Heart Journal · 2023
168. Transcatheter Mitral Valve Repair for Degenerative Mitral RegurgitationJAMA · 2023
169. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 TrialCirculation · 2023
170. Cerebral Embolic Protection in Transcatheter Aortic Valve ReplacementStructural Heart · 2023
171. The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III SubstudyJournal of the Society for Cardiovascular Angiography & Interventions · 2023
172. Transcatheter Left Ventricular Restoration in Patients With Heart FailureJournal of Cardiac Failure · 2023
173. Cardiac Computed Tomography Angiography Anatomical Characterization of Patients Screened for a Dedicated Transfemoral Transcatheter Valve System for Primary Aortic RegurgitationStructural Heart · 2023
174. Pericoronary Adipose Tissue Attenuation in Patients With Acute Coronary Syndrome Versus Stable Coronary Artery DiseaseCirculation Cardiovascular Imaging · 2023
175. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trialsEuropean Heart Journal · 2023
176. The Multidisciplinary Heart Team in Cardiovascular MedicineJACC Advances · 2023
177. Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims dataAmerican Heart Journal · 2022
178. Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized TrialsJournal of the American Heart Association · 2022
179. Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER TrialCirculation Cardiovascular Interventions · 2022
180. Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitationEuropean Heart Journal · 2022
181. Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIJournal of the Society for Cardiovascular Angiography & Interventions · 2022
182. Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and RegistriesJournal of the Society for Cardiovascular Angiography & Interventions · 2022
183. Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the FutureStructural Heart · 2022
184. Long-Term Outcomes of Randomized Controlled Trials Comparing Percutaneous Left Atrial Appendage Closure to Oral Anticoagulation for Nonvalvular Atrial Fibrillation: A Meta-AnalysisStructural Heart · 2022
185. Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve StudyStructural Heart · 2022
186. In-Hospital Outcomes of Transcatheter Tricuspid Valve Repair: An Analysis From the National Inpatient SampleJournal of the Society for Cardiovascular Angiography & Interventions · 2022
187. Interaction between secondary mitral regurgitation and left atrial function and their prognostic implications after cardiac resynchronization therapyEuropean Heart Journal - Cardiovascular Imaging · 2022
188. Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical OutcomesJAMA Cardiology · 2022
189. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve ReplacementJournal of the American College of Cardiology · 2022
190. Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve ReplacementJAMA Cardiology · 2022
191. Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosisHeart · 2022
192. Prognostic Implications of Change in Left Ventricular Ejection Fraction After Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology · 2022
193. Sex-Related Differences in Medically Treated Moderate Aortic StenosisSHILAP Revista de lepidopterología · 2022
194. Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and RegistriesJournal of the American Heart Association · 2022
195. Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled TrialsJournal of the Society for Cardiovascular Angiography & Interventions · 2022
196. Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black AdultsJAMA Network Open · 2022
197. Reasons for lesion uncrossability as assessed by intravascular ultrasoundCatheterization and Cardiovascular Interventions · 2022
198. Minimum Core Data Elements for Evaluation of TAVRJACC: Cardiovascular Interventions · 2022
199. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive CardiomyopathyJAMA Cardiology · 2022
200. Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real‐world comparative analysisCatheterization and Cardiovascular Interventions · 2022